-transparent.png){kind=logo}
Percutaneous transluminal coronary laser angioplasty is still undergoing clinical trials. The laser systems employed are of the pulsed type - for the most part the excimer laser - which are more effective for removing calcified plaque and have a lower complication rate than continuous wave lasers. While the long-term results are comparable with those achieved with balloon dilatation, the primary success rate of laser angioplasty alone is not yet up to the standards of balloon angioplasty. Improvements may be expected through the further development of catheter systems and the introduction of new techniques with more accurate and specific ablation of arteriosclerotic plaques.
A Baumbach, and
K K Haase, and
K R Karsch
January 1986,
Cardiovascular and interventional radiology,
A Baumbach, and
K K Haase, and
K R Karsch
March 1993,
British heart journal,
A Baumbach, and
K K Haase, and
K R Karsch
November 1989,
Zeitschrift fur Kardiologie,
A Baumbach, and
K K Haase, and
K R Karsch
April 1992,
American heart journal,
A Baumbach, and
K K Haase, and
K R Karsch
November 1993,
Circulation,
A Baumbach, and
K K Haase, and
K R Karsch
November 1986,
Heart & lung : the journal of critical care,
A Baumbach, and
K K Haase, and
K R Karsch
January 1991,
The Medical letter on drugs and therapeutics,
A Baumbach, and
K K Haase, and
K R Karsch
January 1994,
Lasers in surgery and medicine,
A Baumbach, and
K K Haase, and
K R Karsch
April 1987,
British journal of hospital medicine,
A Baumbach, and
K K Haase, and
K R Karsch
April 2003,
Nihon rinsho. Japanese journal of clinical medicine,
